BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/01/1994

Prospective Grant of Exclusive License: Cell Stress Transcriptional Factors

The National Institutes of Health (NIH) is contemplating the grant of an exclusive world-wide license to StressTech Biomedical, Inc. for the invention embodied in U.S. Patent Application SN 07/617,910, entitled 'Cell Stress Transcriptional Factors'. The license will be royalty-bearing and limited to commercial screening assay services and kits.

Source: Federal Register — Health and Human ServicesOpen original release →
Related company profile: CiscoOpen profile →